Vect-Horus has a clinical-phase solution to a key drug development challenge: crossing the blood–brain barrier (BBB). By targeting receptors on the barrier, Vect-Horus is empowering partners such as ...

The Non-Fluorinated Barrier Technology Market begins at approximately USD 0.9 billion in 2025 and crosses USD 1.0 billion in 2026 as major global brands accelerate PFAS elimination strategies. By 2030 ...

STOCKHOLM, Nov. 14, 2022 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US Patent and Trademark Office (USPTO) has granted BioArctic a new platform patent for ...

Tetra Pak takes another major step towards the next generation of sustainable packaging materials with its €60 million investment in a new pilot plant for its paper-based barrier technology at the ...